Research Article
Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients
| | Number of cases |
| Total number of patients | 110 |
| Prostate cancer patients | 55 | Gleason score | | 6 | 19 | 7 | 25 | 8–10 | 8 | Unknown | 3 | Pathological stage | | pT2a | 13 | pT2b | 1 | pT2c | 13 | pT3a | 16 | pT3b | 1 | Unknown | 11 | Median PSA (range) | 6.32 (3.1–118.4) | Median UCF-DNA integrity (range) | 0.06 (0–2.56) |
| Patients with benign diseases | 55 | Benign prostatic disease | 23 | Benign kidney and bladder diseases | 21 | Others | 11 | Median PSA (range) | 1.38 (0–14.00) | Median UCF-DNA integrity (range) | 0.06 (0–3.41) |
|
|
Patients without PSA and UCF-DNA integrity results were excluded; UCF: urine cell-free.
|